Diuretic therapy in congestive heart failure

References

• Hunt SA. American College of C, American Heart Association Task Force on Practice G. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46(6):e1-82.
   PubMed Web of Science ®Google Scholar
• Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977–2016.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628–651.
   PubMed Web of Science ®Google Scholar
• Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337(19):1360–1369.
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.
   PubMed Web of Science ®Google Scholar
• Ryden-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med. 1999;246(3):275–284.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Albert NM, Allen LA, Stroke Council, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–619.
   PubMed Web of Science ®Google Scholar
• Pellicori P, Kaur K, Clark AL. Fluid management in patients with chronic heart failure. Card Fail Rev. 2015;1(2):90–95.
   PubMedGoogle Scholar
• de Silva R, Rigby AS, Witte KK, et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol. 2006;98(3):391–398.
   PubMed Web of Science ®Google Scholar
• Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589–596.
   PubMed Web of Science ®Google Scholar
• Damman K, van Deursen VM, Navis G, et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53(7):582–588.
   PubMed Web of Science ®Google Scholar
• Colombo PC, Onat D, Harxhi A, et al. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J. 2014;35(7):448–454.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, Bueno H, Document Reviewers, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Dynamed. Diuretics for Heart Failure. [Internet] Ipswich (MA): EBSCO Information Services 1995 – Record No T901136. 2018.
   Google Scholar
• Brater C. Mechanism of action of diuretics. Waltham, MA: UpToDate; 2020.
   Google Scholar
• Swedberg K, Cleland J, Dargie H, Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26(11):1115–1140.
   PubMed Web of Science ®Google Scholar
• McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441–1446.
   PubMed Web of Science ®Google Scholar
• Eriksson H, Caidahl K, Larsson B, et al. Cardiac and pulmonary causes of dyspnoea-validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J. 1987;8(9):1007–1014.
   PubMed Web of Science ®Google Scholar
• Carlson KJ, Lee DC, Goroll AH, et al. An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis. 1985;38(9):733–739.
   PubMedGoogle Scholar
• Lindenfeld JAnn, Albert NM, Boehmer JP, Heart Failure Society of America, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16(6):e1–194. Commentary can be found in J Card Fail 2011;17(1):1.
   PubMed Web of Science ®Google Scholar
• Thibodeau JT, Drazner MH. The role of the clinical examination in patients with heart failure. JACC Heart Fail. 2018;6(7):543–551.
   PubMed Web of Science ®Google Scholar
• NICE. Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance. BMJ. 2018;362:k4080.
   PubMedGoogle Scholar
• Wargo KA, Banta WM. A comprehensive review of the loop diuretics: should furosemide be first line? Ann Pharmacother. 2009;43(11):1836–1847.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio JJ. Should torsemide be the loop diuretic of choice in systolic heart failure? Future Cardiol. 2012;8(5):707–728.
   PubMedGoogle Scholar
• Murray MD, Deer MM, Ferguson JA, et al. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med. 2001;111(7):513–520.
   PubMed Web of Science ®Google Scholar
• Cosin J, Diez J, Investigators T. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail. 2002;4(4):507–513.
   PubMed Web of Science ®Google Scholar
• Lapsia V, Kazory A. Loop diuretics for heart failure-associated hyponatremia. Am J Med. 2010;123(8):e5–e6.
   PubMed Web of Science ®Google Scholar
• McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995–2008.
   PubMed Web of Science ®Google Scholar
• Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135–R46.
   PubMed Web of Science ®Google Scholar
• Velazquez H, Wright FS. Control by drugs of renal potassium handling. Annu Rev Pharmacol Toxicol. 1986;26:293–309.
   PubMed Web of Science ®Google Scholar
• Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992;267(8):1083–1089.
   PubMed Web of Science ®Google Scholar
• Nilsson E, Gasparini A, Arnlov J, et al. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J Cardiol. 2017;245:277–284.
   PubMed Web of Science ®Google Scholar
• Palmer BF. Metabolic complications associated with use of diuretics. Semin Nephrol. 2011;31(6):542–552.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Georgianos PI, Lasaridis AN. Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin Drug Saf. 2010;9(2):259–273.
   PubMed Web of Science ®Google Scholar
• Blanning A, Westfall JM, Shaughnessy AF. Clinical inquiries. How soon should serum potassium levels be monitored for patients started on diuretics? J Fam Pract. 2001;50(3):207–208.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Kowey PR, Whelton PK, et al. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160(16):2429–2436.
   PubMedGoogle Scholar
• Ayus JC. Diuretic-induced hyponatremia. Arch Intern Med. 1986;146(7):1295–1296.
   PubMedGoogle Scholar
• Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70(6):1163–1168.
   PubMed Web of Science ®Google Scholar
• Szatalowicz VL, Miller PD, Lacher JW, et al. Comparative effect of diuretics on renal water excretion in hyponatraemic oedematous disorders. Clin Sci (Lond). 1982;62(2):235–238.
   PubMed Web of Science ®Google Scholar
• Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993;103(2):601–606.
   PubMed Web of Science ®Google Scholar
• Bruderer S, Bodmer M, Jick SS, et al. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol. 2014;66(1):185–196.
   PubMed Web of Science ®Google Scholar
• McAdams DeMarco MA, Maynard JW, Baer AN, et al. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study. Arthritis Rheum. 2012;64(1):121–129.
   PubMed Web of Science ®Google Scholar
• Sica DA, Carter B, Cushman W, et al. Thiazide and loop diuretics. J Clin Hypertens (Greenwich). 2011;13(9):639–643.
   PubMed Web of Science ®Google Scholar
• Leitzmann MF, Tsai CJ, Stampfer MJ, et al. Thiazide diuretics and the risk of gallbladder disease requiring surgery in women. Arch Intern Med. 2005;165(5):567–573.
   PubMedGoogle Scholar
• Casu G, Merella P. Diuretic therapy in heart failure - current approaches. Eur Cardiol. 2015;10(1):42–47.
   PubMed Web of Science ®Google Scholar
• Wrenger E, Muller R, Moesenthin M, et al. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. BMJ. 2003;327(7407):147–149.
   PubMed Web of Science ®Google Scholar
• Sidhu K, Sanjanwala R, Zieroth S. Hyperkalemia in heart failure. Curr Opin Cardiol. 2020;35(2):150–155.
   PubMed Web of Science ®Google Scholar
• Brater DC. Diuretic therapy. N Engl J Med. 1998;339(6):387–395.
   PubMed Web of Science ®Google Scholar
• Brater DC. Update in diuretic therapy: clinical pharmacology. Semin Nephrol. 2011;31(6):483–494.
   PubMed Web of Science ®Google Scholar
• Hafizullah M. Comparative efficacy and tolerability of lasoride and spiromide in congestive cardiac failure. J Postgrad Med Inst. 2011;14(1):36–42.
   Google Scholar
• Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999;100(12):1311–1315.
   PubMed Web of Science ®Google Scholar
• Petri M, Cumber P, Grimes L, et al. The metabolic effects of thiazide therapy in the elderly: a population study. Age Ageing. 1986;15(3):151–155.
   PubMed Web of Science ®Google Scholar
• Dyckner T, Wester PO. Effects of magnesium infusions in diuretic induced hyponatraemia. Lancet. 1981;1(8220 Pt 1):585–586.
   PubMed Web of Science ®Google Scholar
• Cook DJ, Tudball CF. Potentiators and bolus intravenous furosemide. Lancet. 2001;358(9290):1373–1374.
   PubMed Web of Science ®Google Scholar
• Gallagher KL, Jones JK. Furosemide-induced ototoxicity. Ann Intern Med. 1979;91(5):744–745.
   PubMed Web of Science ®Google Scholar
• Delpire E, Lu J, England R, et al. Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet. 1999;22(2):192–195.
   PubMed Web of Science ®Google Scholar
• Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2004;(3):CD003178. DOI:https://doi.org/10.1002/14651858.CD003178.pub3
   Google Scholar
• Raftery EB. Haemodynamic effects of diuretics in heart failure. Br Heart J. 1994;72(2 Suppl):S44–S7.
   PubMedGoogle Scholar
• Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9(10):1064–1069.
   PubMed Web of Science ®Google Scholar
• Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997;62(2):187–193.
   PubMed Web of Science ®Google Scholar
• Wilcox CS, Mitch WE, Kelly RA, et al. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med. 1983;102(3):450–458.
   PubMed Web of Science ®Google Scholar
• Hammarlund MM, Odlind B, Paalzow LK. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther. 1985;233(2):447–453.
   PubMed Web of Science ®Google Scholar
• Cook JA, Smith DE. Development of acute tolerance to bumetanide: bolus injection studies. Pharm Res. 1987;4(5):379–384.
   PubMed Web of Science ®Google Scholar
• Cook JA, Smith DE. Development of acute tolerance to bumetanide: constant-rate infusion studies. Pharm Res. 1988;5(2):86–91.
   PubMed Web of Science ®Google Scholar
• ter Maaten JM, Valente MA, Damman K, et al. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12(3):184–192.
   PubMed Web of Science ®Google Scholar
• Ellison DH. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med. 1991;114(10):886–894.
   PubMed Web of Science ®Google Scholar
• Trullas JC, Casado J, Morales-Rull JL, et al. Prevalence and outcome of diuretic resistance in heart failure. Intern Emerg Med. 2019;14(4):529–537.
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Heart J Suppl. 2005;7(suppl_B):B13–B19.
   Web of Science ®Google Scholar
• Jardim SI, Ramos Dos Santos L, Araujo I, et al. A 2018 overview of diuretic resistance in heart failure. Rev Port Cardiol. 2018;37(11):935–945.
   PubMedGoogle Scholar
• Iqbal J, Javaid MM. Diuretic resistance and its management. Br J Hosp Med (Lond). 2014;75(7):C103–7.
   PubMed Web of Science ®Google Scholar
• Shah N, Madanieh R, Alkan M, et al. A perspective on diuretic resistance in chronic congestive heart failure. Ther Adv Cardiovasc Dis. 2017;11(10):271–278.
   PubMedGoogle Scholar
• De Bruyne LK. Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J. 2003;79(931):268–271.
   PubMed Web of Science ®Google Scholar
• Ronco C, Ricci Z, Bellomo R, et al. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology. 2001;96(3-4):155–168.
   PubMed Web of Science ®Google Scholar
• Shi X, Bao J, Zhang H, et al. Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Fail Rev. 2019;24(6):927–940.
   PubMed Web of Science ®Google Scholar
• Verbrugge FH, Mullens W, Tang WH. Management of cardio-renal syndrome and diuretic resistance. Curr Treat Options Cardiovasc Med. 2016;18(2):11.
   PubMedGoogle Scholar
• Udelson JE, Bilsker M, Hauptman PJ, et al. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction. J Card Fail. 2011;17(12):973–981.
   PubMed Web of Science ®Google Scholar
• Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol. 1999;34(1):155–162.
   PubMed Web of Science ®Google Scholar
• Publication Committee for the VI. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287(12):1531–1540.
   PubMed Web of Science ®Google Scholar